“…Despite the presence of abnormalities in liver function tests, the course of liver involvement in our patient has been benign so far, without progressive cirrhosis or liver failure. Presently, our patients are being treated with ursodeoxycholic acid, a secondary bile acid that regulates cholesterol levels by slowing down the rate of intestinal absorption of cholesterol and is used to treat various liver disorders such as cholestasis, non‐alcoholic steatohepatitis, non‐alcoholic fatty liver disease, intrahepatic cholestasis of pregnancy, primary biliary cirrhosis, hepatitis C virus infection, and hepatobiliary disorders in children 23 . There is no definitive treatment available for MAS yet 10 .…”